Cancer Research Audrey Hepburn  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, Y. J.
Right arrow Articles by Diamond, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, Y. J.
Right arrow Articles by Diamond, A. M.
[Cancer Research 63, 3347-3351, June 15, 2003]
© 2003 American Association for Cancer Research


Molecular Biology and Genetics

Role of Glutathione Peroxidase 1 in Breast Cancer

Loss of Heterozygosity and Allelic Differences in the Response to Selenium1

Ya Jun Hu and Alan M. Diamond2

Department of Human Nutrition, University of Illinois at Chicago, Chicago, Illinois 60612

A role for allelic variation within the gene for the antioxidant selenoprotein glutathione peroxidase 1 (GPx-1) in the risk or etiology of breast cancer was investigated. By analyzing the frequency of a polymorphism within the GPx-1 gene resulting in a leucine or proline at codon 198, it was determined that the leucine-containing allele was more frequently associated with breast cancer than the proline-containing allele (odds ratio = 1.9; P < 0.05). However, the heterozygosity index for this polymorphism was lower in the breast cancer samples. To determine whether this was because of the loss of heterozygosity (LOH) during tumor development, another polymorphic marker within GPx-1, which is frequently heterozygous in the human population, was analyzed. These studies indicated that LOH at this locus is a frequent event, occurring in approximately 36% of the breast tumor DNAs analyzed. The consequences of the identity of the amino acid at position 198 were investigated by engineering breast carcinoma cells that exclusively express either the leucine- or proline-containing GPx-1 allele and studying the response to increasing concentrations of selenium. These studies indicated that the leucine-containing allele was less responsive to the stimulation of GPx-1 enzyme activity observed during selenium supplementation than the allele differing only by a proline at that position. These studies support a role for GPx-1 allelic identity and LOH as factors of significance to breast cancer development.




This article has been cited by other articles:


Home page
Toxicol SciHome page
M. Farina, F. Campos, I. Vendrell, J. Berenguer, M. Barzi, S. Pons, and C. Sunol
Probucol Increases Glutathione Peroxidase-1 Activity and Displays Long-Lasting Protection against Methylmercury Toxicity in Cerebellar Granule Cells
Toxicol. Sci., December 1, 2009; 112(2): 416 - 426.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Zhuo, M. Goldberg, L. Herman, B.-S. Lee, H. Wang, R. L. Brown, C. B. Foster, U. Peters, and A. M. Diamond
Molecular Consequences of Genetic Variations in the Glutathione Peroxidase 1 Selenoenzyme
Cancer Res., October 15, 2009; 69(20): 8183 - 8190.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Bhatti, P. A. Stewart, A. Hutchinson, N. Rothman, M. S. Linet, P. D. Inskip, and P. Rajaraman
Lead Exposure, Polymorphisms in Genes Related to Oxidative Stress, and Risk of Adult Brain Tumors
Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1841 - 1848.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. Grumolato, H. Ghzili, M. Montero-Hadjadje, S. Gasman, J. Lesage, Y. Tanguy, L. Galas, D. Ait-Ali, J. Leprince, N. C. Guerineau, et al.
Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion
FASEB J, June 1, 2008; 22(6): 1756 - 1768.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. E Fabre, A. Raynaud-Simon, J.-L. Golmard, M. Hebert, X. Dulcire, M. Succari, J. Myara, D. Durand, and V. Nivet-Antoine
Gene polymorphisms of oxidative stress enzymes: prediction of elderly renutrition
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1504 - 1512.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Juliger, H. Goenaga-Infante, T. A. Lister, J. Fitzgibbon, and S. P. Joel
Chemosensitization of B-Cell Lymphomas by Methylseleninic Acid Involves Nuclear Factor-{kappa}B Inhibition and the Rapid Generation of Other Selenium Species
Cancer Res., November 15, 2007; 67(22): 10984 - 10992.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. C. Mathers and J. E. Hesketh
The Biological Revolution: Understanding the Impact of SNPs on Diet-Cancer Interrelationships
J. Nutr., January 1, 2007; 137(1): 253S - 258S.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
B. Moghadaszadeh and A. H. Beggs
Selenoproteins and Their Impact on Human Health Through Diverse Physiological Pathways.
Physiology, October 1, 2006; 21(5): 307 - 315.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. Karunasinghe, L. R. Ferguson, J. Tuckey, and J. Masters
Hemolysate Thioredoxin Reductase and Glutathione Peroxidase Activities Correlate with Serum Selenium in a Group of New Zealand Men at High Prostate Cancer Risk
J. Nutr., August 1, 2006; 136(8): 2232 - 2235.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Diwadkar-Navsariwala, G. S. Prins, S. M. Swanson, L. A. Birch, V. H. Ray, S. Hedayat, D. L. Lantvit, and A. M. Diamond
Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model
PNAS, May 23, 2006; 103(21): 8179 - 8184.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Ravn-Haren, A. Olsen, A. Tjonneland, L. O. Dragsted, B. A. Nexo, H. Wallin, K. Overvad, O. Raaschou-Nielsen, and U. Vogel
Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study
Carcinogenesis, April 1, 2006; 27(4): 820 - 825.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Sutton, P. Nahon, D. Pessayre, P. Rufat, A. Poire, M. Ziol, D. Vidaud, N. Barget, N. Ganne-Carrie, N. Charnaux, et al.
Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis.
Cancer Res., March 1, 2006; 66(5): 2844 - 2852.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Cebrian, P. D. Pharoah, S. Ahmed, P. L. Smith, C. Luccarini, R. Luben, K. Redman, H. Munday, D. F. Easton, A. M. Dunning, et al.
Tagging Single-Nucleotide Polymorphisms in Antioxidant Defense Enzymes and Susceptibility to Breast Cancer
Cancer Res., January 15, 2006; 66(2): 1225 - 1233.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. Hu, R. V. Benya, R. E. Carroll, and A. M. Diamond
Allelic Loss of the Gene for the GPX1 Selenium-Containing Protein Is a Common Event in Cancer
J. Nutr., December 1, 2005; 135(12): 3021S - 3024S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Ahn, M. D. Gammon, R. M. Santella, M. M. Gaudet, J. A. Britton, S. L. Teitelbaum, M. B. Terry, A. I. Neugut, and C. B. Ambrosone
No Association Between Glutathione Peroxidase Pro198Leu Polymorphism and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2459 - 2461.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. A. Carlson, X.-M. Xu, V. N. Gladyshev, and D. L. Hatfield
Selective Rescue of Selenoprotein Expression in Mice Lacking a Highly Specialized Methyl Group in Selenocysteine tRNA
J. Biol. Chem., February 18, 2005; 280(7): 5542 - 5548.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. G. Cox, S. E. Hankinson, P. Kraft, and D. J. Hunter
No Association between GPX1 Pro198Leu and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1821 - 1822.
[Full Text] [PDF]


Home page
J. Nutr.Home page
V. Diwadkar-Navsariwala and A. M. Diamond
The Link between Selenium and Chemoprevention: A Case for Selenoproteins
J. Nutr., November 1, 2004; 134(11): 2899 - 2902.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. M. Diamond
On the road to selenocysteine
PNAS, September 14, 2004; 101(37): 13395 - 13396.
[Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Milner
Molecular Targets for Bioactive Food Components
J. Nutr., September 1, 2004; 134(9): 2492S - 2498S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
U. Vogel, A. Olsen, H. Wallin, K. Overvad, A. Tjonneland, and B. A. Nexo
No Association between GPX Pro198Leu and Risk of Basal Cell Carcinoma
Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1412 - 1413.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. R. Taylor, H. L. Parnes, and S. M. Lippman
Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis
J Natl Cancer Inst, May 5, 2004; 96(9): 645 - 647.
[Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Milner
Incorporating Basic Nutrition Science into Health Interventions for Cancer Prevention
J. Nutr., November 1, 2003; 133(11): 3820S - 3826.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.